Outcomes for immuno-chemotherapy based treatment in patients with poorly differentiated extrapulmonary neuroendocrine carcinoma

被引：0
|
作者：
Kumar, Sakthi
Talabi, Toluwalase
Mahmoudieh, Mahta
Pennington, Daniel
Saboda, Kathylynn
Arshad, Junaid
Scott, Aaron James
机构：
[1] Univ Arizona, Ctr Canc, Tucson, AZ USA
[2] Univ Arizona, Coll Med Tucson, Tucson, AZ USA
[3] Univ Arizona, Dept Neurosci, Tucson, AZ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14619
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Selection of Chemotherapy in Advanced Poorly Differentiated Extra-Pulmonary Neuroendocrine Carcinoma
    Weaver, Jamie M. J.
    Hubner, Richard A.
    Valle, Juan W.
    Mcnamara, Mairead G.
    CANCERS, 2023, 15 (20)
  • [22] Curative surgery after neoadjuvant chemotherapy in metastatic poorly differentiated neuroendocrine carcinoma
    Sorbye, H.
    Westre, B.
    Horn, A.
    EJSO, 2007, 33 (10): : 1209 - 1210
  • [23] Locoregional immuno-chemotherapy in liver carcinoma - Present and future
    Okuno, K
    Yasutomi, M
    HEPATO-GASTROENTEROLOGY, 1995, 42 (05) : 578 - 586
  • [24] Bevacizumab-based Chemotherapy for Poorly-differentiated Neuroendocrine Tumors
    Collot, Thomas
    Fumet, Jean-David
    Klopfenstein, Quentin
    Vincent, Julie
    Bengrine, Leila
    Ghiringhelli, Francois
    ANTICANCER RESEARCH, 2018, 38 (10) : 5963 - 5968
  • [25] Irinotecan-Based Regimens for the Second-Line Treatment of Extrapulmonary Poorly Differentiated Neuroendocrine Carcinomas: A Monocentric Experience
    Bardasi, C.
    Caputo, F.
    Santini, C.
    Cerma, K.
    Gardini, Casadei A.
    Andrikou, K.
    Salati, M.
    Fontana, A.
    Spallanzani, A.
    Bertolini, F.
    Luppi, G.
    Gelsomino, F.
    NEUROENDOCRINOLOGY, 2020, 110 : 180 - 180
  • [26] Amrubicin monotherapy for patients with extrapulmonary neuroendocrine carcinoma after platinum-based chemotherapy
    Nio, Kenta
    Arita, Shuji
    Isobe, Taichi
    Kusaba, Hitoshi
    Kohashi, Kenichi
    Kajitani, Tatsuhiro
    Tamura, Shingo
    Hirano, Gen
    Mitsugi, Kenji
    Makiyama, Akitaka
    Esaki, Taito
    Ariyama, Hiroshi
    Oda, Yoshinao
    Akashi, Koichi
    Baba, Eishi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (04) : 829 - 835
  • [27] Amrubicin monotherapy for patients with extrapulmonary neuroendocrine carcinoma after platinum-based chemotherapy
    Kenta Nio
    Shuji Arita
    Taichi Isobe
    Hitoshi Kusaba
    Kenichi Kohashi
    Tatsuhiro Kajitani
    Shingo Tamura
    Gen Hirano
    Kenji Mitsugi
    Akitaka Makiyama
    Taito Esaki
    Hiroshi Ariyama
    Yoshinao Oda
    Koichi Akashi
    Eishi Baba
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 829 - 835
  • [28] Poorly differentiated neuroendocrine carcinoma of the seminal vesicle
    Yasunaga, Yutaka
    Ueda, Takafumi
    Kodama, Yoshinori
    Oka, Toshitsugu
    INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 (04) : 370 - 372
  • [29] A poorly differentiated thyroid carcinoma with neuroendocrine traits
    Boronat, M
    Isla, C
    Nóvoa, FJ
    Cabrera, JJ
    THYROID, 2004, 14 (02) : 163 - 164
  • [30] Multicenter retrospective analysis of systemic chemotherapy in poorly differentiated neuroendocrine carcinoma of the digestive system
    Yamaguchi, Tomohiro
    Machida, Nozomu
    Kasuga, Akiyoshi
    Takahashi, Hideaki
    Sudo, Kentaro
    Nishina, Tomohiro
    Tobimatsu, Kazutoshi
    Ishido, Kenji
    Furuse, Junji
    Boku, Narikazu
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
12345